These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3127596)

  • 41. [Changes in the blood proteolytic activity of patients with acute burn toxemia].
    Kamaev MF; Vashchuk VV
    Probl Gematol Pereliv Krovi; 1976 Aug; 21(8):20-2. PubMed ID: 967838
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of phosphate supplementation on Pseudomonas aeruginosa invasive behavior in burn wound infections: A simple approach to a big problem.
    Mohammadi-Samani S; Kouroshfard S; Azarpira N
    Burns; 2016 Mar; 42(2):428-33. PubMed ID: 26787129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection.
    Silver GM; Gamelli RL; O'Reilly M
    Surgery; 1989 Aug; 106(2):452-5; discussion 455-6. PubMed ID: 2474866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burn injury with infection alters prostaglandin E2 synthesis and metabolism.
    Hahn EL; Tai HH; He LK; Gamelli RL
    J Trauma; 1999 Dec; 47(6):1052-7; discussion 1057-9. PubMed ID: 10608532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth of Pseudomonas aeruginosa in normal and burned skin extract: role of extracellular proteases.
    Cicmanec JF; Holder IA
    Infect Immun; 1979 Aug; 25(2):477-83. PubMed ID: 114486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic inflammatory responses and multiple organ dysfunction syndrome following skin burn wound and Pseudomonas aeruginosa infection in mice.
    Li N; Hu X; Liu Y; Wang Y; Wang Y; Liu J; Cai W; Bai X; Zhu X; Han J; Hu D
    Shock; 2013 Aug; 40(2):152-9. PubMed ID: 23707977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Local Application of Probiotic Bacteria Prophylaxes against Sepsis and Death Resulting from Burn Wound Infection.
    Argenta A; Satish L; Gallo P; Liu F; Kathju S
    PLoS One; 2016; 11(10):e0165294. PubMed ID: 27780258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Convalescent burn plasma therapy for severely burned children. Control study of 81 cases and tests for Pseudomonas antibodies.
    Bocanegra M; Hinostroza F; Bazan A; Velarde N; Yoza V; Rosenthal SM
    Ann Surg; 1966 Mar; 163(3):461-9. PubMed ID: 4955895
    [No Abstract]   [Full Text] [Related]  

  • 49. Epidemiologic and Bacteriologic Study of the Burned Patients from the Plastic Surgery Department of the County Emergency Hospital of Ploieşti, over a 4 Years Period (2010-2013).
    Zbuchea A; Racasan O; Falca V; Mitache C; Vladescu C
    Chirurgia (Bucur); 2015; 110(4):362-7. PubMed ID: 26305201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
    Fox CL; Modak SM; Stanford JW
    Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The invasion of burned skin by Pseudomonas aeruginosa.
    Carney SA; Dyster RE; Jones RJ
    Br J Dermatol; 1973 Jun; 88(6):539-45. PubMed ID: 4197888
    [No Abstract]   [Full Text] [Related]  

  • 52. Heparinase Is Essential for Pseudomonas aeruginosa Virulence during Thermal Injury and Infection.
    Dzvova N; Colmer-Hamood JA; Griswold JA; Hamood AN
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chemoprophylaxis and therapy of wound infection, especially of burn wounds].
    Mittelbach HR
    Ther Ggw; 1970 Dec; 109(12):1761-2 passim. PubMed ID: 4992973
    [No Abstract]   [Full Text] [Related]  

  • 54. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
    Valdéz JC; Peral MC; Rachid M; Santana M; Perdigón G
    Clin Microbiol Infect; 2005 Jun; 11(6):472-9. PubMed ID: 15882197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
    Ullah F; Malik SA; Ahmed J
    Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An evaluation of pediatric burn patients over a 15-year period.
    Tekin R; Yolbaş I; Selçuk CT; Güneş A; Ozhasanekler A; Aldemir M
    Ulus Travma Acil Cerrahi Derg; 2012 Nov; 18(6):514-8. PubMed ID: 23588911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of granulocyte colony-stimulating factor (G-CSF) upon burn-induced defective neutrophil chemotaxis.
    Sartorelli KH; Silver GM; Gamelli RL
    J Trauma; 1991 Apr; 31(4):523-9; discussion 529-30. PubMed ID: 2020039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Endotoxemia in severely burned patients].
    Yao YM
    Zhonghua Wai Ke Za Zhi; 1993 Jul; 31(7):435-8. PubMed ID: 8313777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR; Zwissler O; Metzger E
    Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.